RDIF and GK “Chemrar” will send a medication for the treatment of coronavirus in Brazil

The company “Chromis”, a joint venture between the Russian direct investment Fund (RDIF) and the group of companies “Chemrar”, signed an agreement with the Brazilian Axis BioTec for the supply of Russian drug Aviewer (favipiravir) for the treatment COVID-19 in Brazil.

Under the terms of the contract before the end of the current year the company “Chromis” put in Brazil a minimum of 100 thousand packages of the drug, in 2021 Brazil will acquire not less than 200 thousand packages.

Drug Aviewer included in the 7th version of the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection, Ministry of health of Russia. From 10 June the drug is already in 50 regions of the Russian Federation. The drug efficacy proven in clinical studies, which were conducted in 35 health centers in Russia with the participation of 330 patients with a confirmed diagnosis COVID-19. The drug blocks the mechanisms of propagation of the coronavirus, relieves symptoms and shortens the disease by half compared with standard therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]